Company Filing History:
1 out of 1 
1 out of 832,843 Years Active: 2019
Title: Innovative Contributions of La Sa in Nucleic Acid Analysis
Introduction: La Sa, an inventor based in Shanghai, China, has made significant contributions to the field of biology with a focus on nucleic acid analysis. With a patent portfolio that includes a novel lytic composition, La Sa's work addresses critical needs in molecular biology research and diagnostics.
Latest Patents: La Sa holds a patent titled "Lytic composition and application thereof, kit, method for preparing nucleic acid by utilizing lytic composition, and nucleic acid analysis method." This invention involves a lytic composition that enables the lysis of multiple biological tissues and cells, releasing nucleic acid directly into a solution. This method eliminates the need for conventional purification processes, allowing researchers to use the nucleic acid in a whole-cell lysing state as a direct template for analysis, such as in real-time fluorescence qPCR.
Career Highlights: Throughout his career, La Sa has worked on advancing the technical field of biology. His innovative approach in developing the lytic product has showcased his commitment to improving nucleic acid analysis methodologies. This invention is particularly beneficial for diagnostics and biotechnological applications.
Collaborations: La Sa has collaborated with notable coworkers in the research landscape, including Xiaohui Wang and Dongjie Sun. Their collective efforts reflect a synergistic partnership in enhancing biological research methods and applications.
Conclusion: La Sa’s contributions to nucleic acid analysis through his patented lytic composition represent a significant leap in the field of molecular biology. His work is a testament to the importance of innovation in foundational scientific research, paving the way for more efficient and effective methods in genetic analysis and related studies.